GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Cyclically Adjusted FCF per Share

Lexagene Holdings (Lexagene Holdings) Cyclically Adjusted FCF per Share : $-0.07 (As of Nov. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Lexagene Holdings's adjusted free cash flow per share for the three months ended in Nov. 2022 was $-0.012. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.07 for the trailing ten years ended in Nov. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-04), Lexagene Holdings's current stock price is $0.0806. Lexagene Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Nov. 2022 was $-0.07. Lexagene Holdings's Cyclically Adjusted Price-to-FCF of today is .


Lexagene Holdings Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Lexagene Holdings's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Cyclically Adjusted FCF per Share Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.48 -0.45 -0.41 -0.30 -0.12

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.16 -0.12 -0.09 -0.08 -0.07

Competitive Comparison of Lexagene Holdings's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Lexagene Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Cyclically Adjusted Price-to-FCF falls into.



Lexagene Holdings Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lexagene Holdings's adjusted Free Cash Flow per Share data for the three months ended in Nov. 2022 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Nov. 2022 (Change)*Current CPI (Nov. 2022)
=-0.012/125.6074*125.6074
=-0.012

Current CPI (Nov. 2022) = 125.6074.

Lexagene Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201212 -0.002 96.871 -0.003
201303 -0.005 98.209 -0.006
201306 -0.016 98.518 -0.020
201309 -0.011 98.790 -0.014
201312 -0.066 98.326 -0.084
201403 0.000 99.695 0.000
201406 -0.027 100.560 -0.034
201409 -0.004 100.428 -0.005
201412 0.001 99.070 0.001
201503 0.002 99.621 0.003
201506 -0.003 100.684 -0.004
201509 -0.008 100.392 -0.010
201512 -0.003 99.792 -0.004
201603 -0.004 100.470 -0.005
201606 -0.002 101.688 -0.002
201609 -0.015 101.861 -0.018
201702 -0.010 102.779 -0.012
201705 -0.012 103.256 -0.015
201708 -0.012 103.587 -0.015
201711 -0.022 104.072 -0.027
201802 -0.023 105.052 -0.028
201805 -0.026 106.148 -0.031
201808 -0.022 106.383 -0.026
201811 -0.024 106.338 -0.028
201902 -0.027 106.649 -0.032
201905 -0.019 108.048 -0.022
201908 -0.016 108.245 -0.019
201911 -0.030 108.519 -0.035
202002 -0.010 109.139 -0.012
202005 -0.019 108.175 -0.022
202008 -0.019 109.662 -0.022
202011 -0.030 109.793 -0.034
202102 -0.019 110.968 -0.022
202105 -0.023 113.576 -0.025
202108 -0.023 115.421 -0.025
202111 -0.020 117.269 -0.021
202202 -0.015 119.703 -0.016
202205 -0.013 123.323 -0.013
202208 -0.012 124.958 -0.012
202211 -0.012 125.607 -0.012

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Lexagene Holdings  (OTCPK:LXXGQ) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Lexagene Holdings Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (Lexagene Holdings) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.